Drug may be alternative to castration

Aug 23, 2006

U.S. medical scientists have found an oral drug is an acceptable alternative to chemical castration to treat prostate cancer.

"In patients with locally-advanced disease, a daily 150 mg dose of bicalutamide (Casodex) following initial radiotherapy has shown significant clinical benefits in terms of overall survival and progression-free survival, compared with radiotherapy alone," said study author Dr. William See, chairman and professor of urology at the Medical College of Wisconsin and chief of urologic surgery at Milwaukee's Froedtert Hospital.

The double-blind, randomized study followed 1,370 early prostate cancer patients who received radiotherapy with curative intent. After a median follow-up of 7.2 years, the researchers found those receiving the daily Casodex regimen reduced their risk of disease progression by 44 percent, and overall risk of death by 35 percent, compared with those receiving a placebo.

"Although many of the adverse effects of castration therapy are manageable, they can have a detrimental effect on quality of life," said See "Here we have evaluated the efficacy and tolerability of a non-castration-based therapy, and found the survival rates to be similar."

The study appears in the Journal of Cancer Research and Clinical Oncology.

Copyright 2006 by United Press International

Explore further: Canada pledges $440 million to vaccinate poor children

add to favorites email to friend print save as pdf

Related Stories

From graphite to water

Sep 17, 2013

Scientists from the National Physical Laboratory (NPL), in collaboration with researchers in Belgium and Italy, have published research that could help provide a primary standard for dose measurements of ...

Cryopreservation: A chance for highly endangered mammals

Feb 28, 2013

Oocytes of lions, tigers and other cat species survive the preservation in liquid nitrogen. Scientists of the Leibniz Institute for Zoo and Wildlife Research (IZW) in Berlin succeeded in carrying out cryopreservation ...

Recommended for you

Syria hit by flesh-eating maggot disease

10 hours ago

Three cases of myiasis have been reported near Damascus, marking the first appearance of the flesh-eating maggot disease in Syria, UN health experts said Friday.

Brazil's Amazon region houses latex 'love factory'

12 hours ago

Deep in Amazonia, Raimundo Pereira expertly cuts a gash in a rubber tree to collect white sap destined for the nearby factory at Xapuri, the world's only producer of contraceptives made from tropical forest latex.

Ebola scare boosts business for US company

12 hours ago

The Ebola scare has subsided in the United States, at least temporarily, but an Alabama manufacturer is still trying to catch up with a glut of orders for gear to protect against the disease.

Sperm can carry Ebola for 82 days: WHO

12 hours ago

Sperm can carry the Ebola virus for at least 82 days, the World Health Organization said Friday, urging men recovering from the disease to use condoms for three months after the onset of symptoms.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.